Skip to Content
You are currently on the new version of our website. Access the old version .

Thalassemia Reports, Volume 16, Issue 2

2026 June - 7 articles

Cover Story: Clinicians now treat thalassemia patients with curative and personalized treatment methods that extend beyond traditional supportive care. In this review, we explore progress in stem cell transplantation, gene therapy, gene editing, and fetal hemoglobin induction and new applications of artificial intelligence. Our findings reveal that future healthcare management will need to combine curative innovation with digital health systems, predictive analytics, and personalized patient risk evaluation. The methods enable medical staff to provide tailored treatment, thus achieving successful results with long-term efficacy. Our findings suggest that the combination of biomedical advancements and smart healthcare systems will lead to significant improvements in thalassemia treatment through the implementation of personalized AI-based systems. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (7)

  • Article
  • Open Access
641 Views
13 Pages

Background: Left ventricular (LV) dysfunction remains the leading cause of mortality in transfusion-dependent beta-thalassemia (TDßT), yet conventional echocardiography often fails to detect early myocardial impairment. This study aimed to comp...

  • Article
  • Open Access
846 Views
15 Pages

Transfusion-Transmitted Risk: High Seroprevalence and Genotypic Diversity of Toxoplasma gondii in Thalassemia Major Calls for Donor Screening Policy Review

  • Mitra Sadeghi,
  • Mohammad Naderi Sorki,
  • Bahareh Basirpour,
  • Hossein Karami and ,
  • Davood Anvari,
  • Seyed Ali Shariatzadeh,
  • Alireza Mohsennejad,
  • Shahabeddin Sarvi,
  • Shirzad Gholami and
  • Sargis. A. Aghayan
  • + 8 authors+ 3 authors

Objectives: Patients with thalassemia major are at high risk of developing blood-borne infections, including toxoplasmosis, due to their dependence on frequent blood transfusions and underlying immune system disorders. This study was designed to inve...

  • Systematic Review
  • Open Access
734 Views
20 Pages

Thalassemia is an inherited hemoglobin disorder caused by reduced or absent globin chain synthesis, with heterogeneous distribution worldwide and in Brazil. Back-ground/Objectives: This systematic review aimed to estimate the frequency of thalas-semi...

  • Article
  • Open Access
1,293 Views
12 Pages

Background: Advances in medical genetics and prenatal diagnosis have improved the detection of fetal abnormalities during pregnancy. The findings may lead some couples to consider termination of pregnancy (TOP). This study aimed to explore parental p...

(This article belongs to the Section Conventional Treatment of Thalassemia)
  • Article
  • Open Access
457 Views
12 Pages

Association Between Plasma Cystatin C Concentration and Urine Osmolality in Adults with Different Forms of Beta-Thalassemia: A Cross-Sectional Study in Vietnam

  • Loan Do Thi Thanh,
  • Anh Nguyen Ngoc,
  • Kien Nguyen Trung,
  • Ha Nguyen Thi Thu and ,
  • Dung Nguyen Huu and
  • Thang Le Viet
  • + 1 author+ 0 author

Objective: To determine plasma cystatin C concentrations, urine osmolality and their relationship with disease severity in beta-thalassemia patients. Methods: A cross-sectional study was conducted on 234 patients with beta-thalassemia, including equa...

  • Review
  • Open Access
3 Citations
3,576 Views
28 Pages

Recent Advances in Thalassemia Management: From Curative Therapies to Artificial Intelligence

  • Mohamed Medhat Abdelwahab Gamaleldin,
  • Shaimaa Mahmoud Nashat Sayed Abdelhalim and
  • Ivo Abraham

Thalassemia is an inherited hemoglobin disorder characterized by chronic hemolytic anemia and substantial long-term healthcare needs. In β-thalassemia major, patients typically require regular red blood cell transfusions with iron chelation to p...

  • Article
  • Open Access
1,410 Views
12 Pages

Implementing Genetic Counseling for Rare Diseases in LMICs: Pediatric and Prenatal Perspectives from India

  • Siddannagoud,
  • Dolat Singh Shekhawat,
  • Kuldeep Singh,
  • Varuna Vyas and ,
  • Pratibha Singh,
  • Charu Sharma,
  • Navdeep Kaur Ghuman and
  • Tanu Gupta
  • + 3 authors+ 0 author

Background: This study investigated the clinical characteristics of consultands and examined their perceived personal control, satisfaction, and decision-making regarding genetic testing, as well as the factors influencing these outcomes, at a tertia...

(This article belongs to the Section Quality of Life)
XFacebookLinkedIn
Thalass. Rep. - ISSN 2039-4365